-
Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright
Source: Buzz FX / 08 Feb 2025 08:41:11 America/New_York
Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Rani Therapeutics ( NASDAQ:RANI - Get Free Report ) 's stock had its "buy" rating reissued by eq
Read more...